FAME aims to a) identify novel lipidomics biomarkers as biomarkers of fatty acid status and
of future cardiometabolic clinical events, b) establish relationships between diet and tissue
status of fatty acids as explanatory factors for diet relationships with cardiometabolic health,
and c) to investigate genetic determinants of fatty acid status and metabolism which modify
the effects of dietary intake. This will allow the identification and validation of novel
biomarkers with the strong potential to define targeted dietary intervention for prevention.